Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss

NEURO-ONCOLOGY

OXFORD UNIV PRESS INC

1. National Cancer Institute
2. NIH [R01CA129371, K24CA125440A]
3. American Brain Foundation
4. American Cancer Society
5. Department of Radiology at the Massachusetts General Hospital